Practice Areas
Life Sciences, Litigation, PatentsIndustry & Technical Focus
Biotechnology, Chemistry, Pharmaceuticals, Antibodies, RNAi
Practice Description
Dr. Dini specializes in patent counseling and strategic planning, including patent prosecution, freedom to operate evaluations, opinion work, and due diligence analyses involving a variety of biotechnologies. He has extensive knowledge in the areas of cellular and molecular biology, biochemistry, genomics, protein chemistry, gene therapy, immunology, RNAi, vaccines, and therapeutic antibodies, and represents a broad range of clients, from start-up biotechnology companies to established biopharmaceutical corporations.
Peter’s doctoral research examined the role of oncogenes in leukemia and his post-doctoral research, conducted at Stanford University and at Harvard Medical School, examined genetic mechanisms in hematopoiesis using embryonic stem cells.
Notable Experience
- Conducting an IP due diligence review of a biotech start-up for a syndicate of venture capital firms involved in a multi-million dollar financing.
- Representing a venture capital firm in evaluating the IP of a Swiss-based drug discovery company prior to a multi-million dollar financing round.
- Serving as U.S. patent counsel to a Swiss-based drug discovery company.
- Representing a privately-held biotechnology company in preparing its IP portfolio prior to its multi-million dollar acquisition by one of the world’s leading research-based pharmaceutical companies.
- Conducting, for a Japan-headquartered pharmaceutical company, an IP due diligence review of an antibody discovery company in preparation for its multi-million dollar acquisition.
Publications & Speaking Engagements
- Speaker, “Antibodies: Overcoming Patentability Hurdles and Claim Drafting Strategies for New Technological Developments,” American Conference Institute Biotech Patents Conference, December 2, 2010.
- Speaker, "Patenting of Therapeutic Antibodies," NRC Biotechnology Research Institute, Montreal, Canada, August 30, 2010.
- Speaker, “An Overview of the Antibody Glycosylation Landscape and Patent Strategies,” NRC Institute for Biological Sciences, Ottawa, Canada, May 27, 2010.
- Speaker, “Antibody Glycosylation: the Technology, the Commercial Landscape & Thoughts on What and How to Patent,” January 2010.
- Panelist, "Biological Sequences: Do’s and Don’ts For Freedom-To-Operate and Patentability Searches," Boston Patent Law Association (BPLA), May 7, 2009.
- Speaker, “On Antibodies…From Market Developments to Patent Protection,” for a group of European patent attorneys in Switzerland, February 2009.
- Speaker, “How Secure is your IP?” at TiE Ottawa, Canada, June 24, 2008.
- Speaker, “What Else Can I Do With My Advanced Degree Beyond Academia and Industry?” presented to graduate students at Boston University Medical School.
- Author of research articles in the Journal of Molecular and Cellular Biology and the Journal of Virology.
